Tag Health & medicine
A Decade of Discovery: ORCHARDS Concludes After Ten Years of Groundbreaking Research
After 10 years, the Oregon Child Absenteeism Due to Respiratory Disease Study has concluded. UW researchers involved with the study reflect on its impact as one of the most comprehensive and long-running community-based studies of respiratory illness in school-aged children in the US.
Bridging the Gap
The UW School of Nursing’s Center for Aging Research and Education (CARE) provides essential support to the growing population of older adults in Wisconsin by educating the next generation of caregivers and engaging with communities to support healthy aging in place.
Research project aims to measure brain fog as long-term effect of COVID-19
The findings of the study could inform the development of more targeted therapies to combat the effects of brain fog, which include memory loss, attention deficits and fatigue, that can make it hard to complete the tasks of daily life.
A new kidney — free of daily meds
Thanks to a cutting-edge clinical trial at UW–Madison, transplant patients are returning to a healthy life without anti-rejection drugs.
The Future of Health
Researchers across the College of Letters & Science are focused on critical topics that will change the way the world looks at medicine, health policy and personal wellness.
With first graduate, accelerated UW program aggressively takes on physician shortage in rural Wisconsin
Shane Hoffman will become the first graduate of a UW School of Medicine and Public Health program that reduces the time it takes to train doctors interested in serving rural parts of the state.
Could an arthritis drug unlock lasting relief from epilepsy and seizures? UW–Madison researchers see promising results in mice.
A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers at UW–Madison. If the drug proves viable for human patients, it would be the first to provide lasting relief from seizures even after they stopped taking it.
NIH funding drives life-saving innovation and economic impact in Wisconsin. University, biomedical and industry leaders issue call to protect it.
Chancellor Mnookin, Universities of Wisconsin, along with industry, university, hospital and health system partners reinforced the importance of NIH funding during a news conference at the UW School of Medicine and Public Health.
UW–Madison center combating opioid overdoses in Wisconsin highlighted in Sen. Baldwin visit
The new Wisconsin Opioid Overdose Response Center is already making important strides toward its mission to equip Wisconsin pharmacies with innovative tools to prevent opioid deaths.
UW researchers find previously unknown links between microbial bile acids and the risk of colon cancer
A team of UW–Madison scientists have uncovered that bile acids produced by the liver to help digest food may affect our risk for developing colon cancer.
Research to treat placenta could improve human pregnancies
In humans, placental insufficiency restricts the growth of developing fetuses and typically leads to premature delivery and extended stays in the neonatal intensive care unit.
UW–Madison researchers use AI to identify sex-specific risks associated with brain tumors
UW–Madison researchers are using AI models to find patterns that could pinpoint characteristics that might help doctors forecast which tumors are likely to grow more quickly.
Update from UW–Madison experts on bird flu spread
UW experts are assisting efforts to track and research the virus with an eye toward minimizing risk to human health and protecting the state’s agricultural sector.
Golden to step down as dean of School of Medicine and Public Health
As one of the longest-serving medical school deans in North America, Golden has led extraordinary advancements in the educational, research and service missions of the school.
Type 2 diabetes may contribute to racial disparities in colorectal cancer among Americans
The findings underscore the value of colonoscopies and other colorectal cancer screenings, especially for Black and lower-income Americans who on average suffer worse outcomes after a cancer diagnosis.
Lauren McLester-Davis becomes UW’s first director of Indigenous science advocacy
In this new position, she will weave together science addressing Alzheimer’s disease and dementias, metabolism, and cognitive aging among Indigenous populations in Wisconsin, and other groups often underrepresented in research.
Wisconsin named National Center of Excellence for wastewater surveillance
Community-focused wastewater surveillance is a cost-effective tool for public health practice. It involves looking for the presence of pathogens that people shed in sewage, whether or not they have symptoms, and measuring the pathogen levels over time.
Brain-penetrating drug candidate effective against deadly encephalitis viruses
The multidisciplinary team of researchers found that BDGR-49 protects mice infected with deadly eastern equine encephalitis virus (EEEV) or Venezuelan equine encephalitis virus (VEEV).
New drug delivery method harnesses clotting to target anti-cancer drugs at tumors
Researchers found that in mice that received the engineered proteins via intravenous injections, the proteins led to clot formation almost exclusively within tumors, with only very limited thrombosis occurring elsewhere.
Health care on the home front: UW grads remain in the state to keep Wisconsin well
Doctors, nurses and pharmacists educated and trained in the UW’s health sciences programs are working in every one of the state’s 72 counties.